Literature DB >> 2310608

Supplemental taurine in diabetic rats: effects on plasma glucose and triglycerides.

H O Goodman1, Z K Shihabi.   

Abstract

The present study has indicated that significant shifts in plasma, urinary, and tissue taurine and in non-taurine dialyzable amines occur in the STZ-induced diabetic rat, especially in the kidney. Taurine administration at relatively low dosage ameliorated only kidney taurine concentration. Anticipated alterations in plasma glucose and creatinine were observed but neither of these changes was affected by taurine administration. Similarly, urinary output of creatinine, glucose, and NAG increased significantly among diabetic rats, but none of these were detectably influenced by taurine. Increases in plasma triglycerides observed in STZ-induced diabetes appear to be attenuated by taurine administration, and although cholesterol concentrations were lower in taurine-treated rats, the differences were not statistically significant. These findings should encourage further studies of these effects in rats as a useful model for several complications of human diabetes including atherosclerosis, retinopathy, and nephropathy.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2310608     DOI: 10.1016/0885-4505(90)90002-i

Source DB:  PubMed          Journal:  Biochem Med Metab Biol        ISSN: 0885-4505


  6 in total

1.  Taurine: A therapeutic agent in experimental kidney disease.

Authors:  H Trachtman; J A Sturman
Journal:  Amino Acids       Date:  1996-03       Impact factor: 3.520

Review 2.  Is taurine beneficial in reducing risk factors for diabetes mellitus?

Authors:  Flavia Franconi; Mauro A S Di Leo; Federico Bennardini; Giovanni Ghirlanda
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

3.  Comparative study of the binding characteristics to and inhibitory potencies towards PARP and in vivo antidiabetogenic potencies of taurine, 3-aminobenzamide and nicotinamide.

Authors:  Kashyap G Pandya; Maulik R Patel; Cesar A Lau-Cam
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

4.  Preventive effect of taurine on experimental type II diabetic nephropathy.

Authors:  Shumei Lin; Jiancheng Yang; Gaofeng Wu; Mei Liu; Xinhong Luan; Qiufeng Lv; He Zhao; Jianmin Hu
Journal:  J Biomed Sci       Date:  2010-08-24       Impact factor: 8.410

Review 5.  The potential usefulness of taurine on diabetes mellitus and its complications.

Authors:  Takashi Ito; Stephen W Schaffer; Junichi Azuma
Journal:  Amino Acids       Date:  2011-03-25       Impact factor: 3.520

6.  Taurine alleviates the progression of diabetic nephropathy in type 2 diabetic rat model.

Authors:  Jang Hyun Koh; Eun Soo Lee; Miri Hyun; Hong Min Kim; Yoon Jung Choi; Eun Young Lee; Dhananjay Yadav; Choon Hee Chung
Journal:  Int J Endocrinol       Date:  2014-02-23       Impact factor: 3.257

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.